[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336621-105":59,"doc-detail-336621-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epigenetic-regulation-of-nkg2d-ligand-and-the-rise-of-nk-cell-based-immunotherapy-for-cancer-treatment","Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment","","Epigenetic modifications shape gene expression and influence cancer initiation, progression, and therapy response, serving as diagnostic and prognostic biomarkers and potential therapeutic targets. Natural killer (NK) cells drive anti-tumor immunity by balancing activating and inhibitory signals through receptor–ligand interactions. This review analyzes epigenetic mechanisms controlling activating NKG2D ligand expression and summarizes clinical trials of NK cell-based immunotherapies. Safety and efficacy case studies across cancer types highlight promising outcomes with limited toxicity, supporting therapeutic potential of epigenetic modulation and guiding future personalized and combination strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epigenetic-regulation-of-nkg2d-ligand-and-the-rise-of-nk-cell-based-immunotherapy-for-cancer-treatment/336621/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epigenetic-regulation-of-nkg2d-ligand-and-the-rise-of-nk-cell-based-immunotherapy-for-cancer-treatment/336621.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How do epigenetic changes contribute to cancer progression and treatment response?","Question",{"text":112,"@type":113},"Epigenetic alterations regulate gene expression without changing DNA sequence. They influence cancer initiation and progression, can affect DNA repair and stemness, and modulate responses to therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role do NK cells play in anti-tumor immunity?",{"text":117,"@type":113},"NK cells recognize and eliminate abnormal cancer cells through receptors that detect specific activating and inhibitory ligands. Upon recognition, they release cytotoxic granules to induce apoptosis.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review focus on regarding NKG2D ligands and immunotherapy?",{"text":121,"@type":113},"The review examines epigenetic modifications that govern activating NKG2D ligand expression and summarizes clinical trials using NK cell-based immunotherapies. It highlights safety and effectiveness across multiple cancer types.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336621,1790907998,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Mini Review  \nPUBLISHED 05 August 2024 DOI 10.3389/fonc.2024.1456631  \nOPEN ACCESS  \nEDITED BY Zhi Sheng,  \nUniversity of South Alabama, United States  \nREVIEWED BY Sanjeev Das,  \nNational Institute of Immunology (NII), India Seema Singh,  \nUniversity of South Alabama, United States  \n*CORRESPONDENCE Romi Gupta  \n [romigup@uab.edu](romigup@uab.edu)  \nRECEIVED 28 June 2024  \nACCEPTED 22 July 2024  \nPUBLISHED 05 August 2024  \nCITATION  \nKumar R and Gupta R (2024) Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment.  \nFront. Oncol. 14:1456631 .  \ndoi: 10.3389/fonc.2024.1456631  \nCOPYRIGHT  \n© 2024 Kumar and Gupta. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nEpigenetic regulation of NKG2D ligand and the rise of NK cellbased immunotherapy for cancer treatment  \nRaj Kumar 1 and Romi Gupta 1,2*  \n1 Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, AL, United States, 2O’ Neal Comprehensive Cancer Center, The University of Alabama at Birmingham, Birmingham, AL, United States  \nEpigenetic modiﬁcations inﬂuence gene expression and effects cancer initiation and progression. Therefore, they serve as diagnostic and prognostic biomarkers and potential therapeutic targets. Natural Killer (NK) cells, integral to the innate immune system, exhibit anti-tumor effect by recognizing and eliminating cancerous cells through the balance of activating and inhibitory ligands. Understanding the epigenetic regulation of NK cell ligands offers insights into enhancing NK cell-mediated tumor eradication . This review explores the epigenetic modiﬁcations governing the expression of activating NKG2D ligandsand discusses clinical trials investigating NK cell-based immunotherapies, highlighting their potential as effective cancer treatment strategies. Case studies examining the safety and effectiveness of NK cell therapies in different cancer types, such as acute myeloid leukemia (AML) and non-small cell lung cancer (NSCLC), demonstrate promising outcomes with minimal toxicity. These ﬁndings underscore the therapeutic prospects of epigenetic modulation of NKG2D ligands and NK cell-based immunotherapies as effective cancer treatment strategies. Future research in the advancement of personalized medicine approaches and novel combination therapies with NK cell will further improve treatment outcomes and provide new therapeutic options for treating patients with various types of cancer.  \nKEYWORDS  \nepigenetics, NK cell, acetylation, methylation, clinical trial  \nIntroduction  \nEpigenetic changes regulating gene expression are those that are independent of alterations in the DNA sequence. These changes can be regulated by numerous factors (1) . Epigenetic regulators mediating epigenetic changes have been shown to play a pivotal role in cancer initiation and progression by regulating the expression of tumor suppressor genes (TSGs) and oncogenes (2) . Moreover, these epigenetic changes impact DNA repair  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \nmechanisms, potentially leading to genomic instability and driving tumorigenesis (3, 4) . They also contribute to maintaining the stemness of cancer cells (5) and regulate responses to therapy (6) . Therefore, they are used as biomarkers for cancer diagnosis and prognosis and represent promising targets for cancer therapy. Understanding the role of epigenetic regulators and epigenetic modiﬁcations in cancer development is essential for unraveling the complexity of the disease and developing effectiv","cbCaihWv0U6CFumP","https://ap.wps.com/l/cbCaihWv0U6CFumP","pdf",355428,"English","# Introduction\n## Epigenetic regulation in cancer\n## NK cell biology and activating/inhibitory balance\n## NKG2D ligands and tumor recognition","[{\"question\":\"How do epigenetic changes contribute to cancer progression and treatment response?\",\"answer\":\"Epigenetic alterations regulate gene expression without changing DNA sequence. They influence cancer initiation and progression, can affect DNA repair and stemness, and modulate responses to therapy.\"},{\"question\":\"What role do NK cells play in anti-tumor immunity?\",\"answer\":\"NK cells recognize and eliminate abnormal cancer cells through receptors that detect specific activating and inhibitory ligands. Upon recognition, they release cytotoxic granules to induce apoptosis.\"},{\"question\":\"What does the review focus on regarding NKG2D ligands and immunotherapy?\",\"answer\":\"The review examines epigenetic modifications that govern activating NKG2D ligand expression and summarizes clinical trials using NK cell-based immunotherapies. It highlights safety and effectiveness across multiple cancer types.\"}]","Epigenetic regulation of NKG2D ligand and the rise of NK cell-based immunotherapy for cancer treatment | PDF",1790015898,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ecd6a109ed109827a41daa867a69dd6c.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/341c7d05b9bc93ad16ada0e2176e4808.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbd6eadea22ac9d418c3eca124bba1e3.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc0284f25be6b2b147dba24f641ebda3.webp",980,1385]